<Blinded Review: TIME_ANON_0479>
**Composite Score:** 3.2 / 10.0 (Rigor: 1.0/3.5 | Claims: 0.9/2.5 | Biology: 0.7/2.0 | Reproducibility: 0.6/2.0)
**Scientific Core Score:** 2.6 / 8.0
**Bias Category:** Statistical/Design
**Verdict:** Reject (Fundamental Flaws)
**Study Modality:** Wet-Lab Primary Experimental
**Technology Maturity:** Commodity/Hype-Cycle Template
**Epistemic Stage:** Clinical/Observational

OVERALL_SCORE: 3.2/10
VERDICT: FAILED
ESTIMATED_DECADE: 2010s

---

### 1. Executive Summary / SUMMARY
This single-center hospital-based case–control study genotypes two SNPs in *CARD8* (`rs2043211` in exon and `rs7253718` in intron) via PCR-RFLP in 118 ankylosing spondylitis (AS) patients and 122 healthy controls from a Chinese Han population. The authors report no statistically significant differences in genotype frequencies for either `rs2043211` or `rs7253718` ($P > 0.05$), a borderline unadjusted allelic association for `rs2043211` T allele ($P = 0.046$, $\text{OR} = 1.441$, $95\%\text{ CI} = 1.006\text{–}2.065$) that loses significance after covariate adjustment ($P = 0.050$, adjusted $\text{OR} = 1.439$, $95\%\text{ CI} = 0.999\text{–}2.072$), a nominal association for the `rs2043211T–rs7253718G` haplotype ($P = 0.008$), and a subgroup association in males. The study is severely underpowered, overinterprets null/borderline findings without multiple-testing correction, omits all data tables (Tables 1–6 and Fig. 1) from the manuscript body, and fails to control properly for the massive confounding difference in HLA-B27 positivity (85% in cases vs. 13.93% in controls).

### 2. Methodological & Statistical Audit / STRENGTHS / WEAKNESSES & METHODOLOGICAL AUDIT

#### STRENGTHS
- Evaluates a biologically plausible candidate variant (`rs2043211`, Cys10Stop nonsense polymorphism in *CARD8*) previously implicated in inflammatory/inflammasome pathways, with age- and sex-matched controls from the same hospital.

#### WEAKNESSES & METHODOLOGICAL AUDIT
- **Severe Underpowering and Claiming Positive Association When Genotype and Adjusted Allelic Tests Are Null:** With only $N = 118$ cases and $N = 122$ controls, the study has $<25\%$ power to detect a realistic common-variant odds ratio of $1.3\text{–}1.4$ at $\alpha = 0.05$. Critically, the genotype comparisons (`TA` and `TT` vs. `AA`) for `rs2043211` are explicitly non-significant ($P > 0.05$ both before and after adjustment, line 71), and the adjusted allelic test has $P = 0.050$ with a 95% confidence interval spanning unity ($0.999\text{–}2.072$). Claiming that `rs2043211` increases AS susceptibility when the primary genotype test and adjusted allelic test fail to reject the null even *before* multiple-testing correction is statistically invalid.
- **No Multiple-Testing Correction Across Genotypes, Alleles, Haplotypes, Age, and Sex Subgroups:** Across 2 SNPs, genotype/allele tests, 3 haplotypes, 2 age strata, and 2 sex strata (>15 tests), no Bonferroni or FDR adjustment is applied. The male-only subgroup finding (`TT` vs. `AA`: $\text{OR} = 2.554$, $95\%\text{ CI} = 1.079\text{–}6.049$ in 82 male cases vs. 78 male controls) is wide, fragile, and unaccompanied by a formal genotype-by-sex interaction test.
- **Confounding by HLA-B27 Status and Unspecified Logistic Regression Covariates:** Line 61 notes that ~85% of AS patients are HLA-B27 positive compared to 13.93% of controls ($P < 0.001$), and family history also differs significantly ($P = 0.006$). The Methods and Results repeatedly state that ORs were "adjusted by clinical features of participants using logistic regression analysis," without specifying which covariates were entered into the regression model or whether HLA-B27 status was controlled for.
- **PCR-RFLP Quality Control and Nonsense Decay / Isoform Ambiguity:** PCR-RFLP with 45 amplification cycles and overnight restriction digestion (`AlwI` and `HindIII`) is prone to partial digestion or heteroduplex artifacts, yet no Sanger sequencing validation or duplicate genotyping concordance rate is reported.
- **Bizarre Exclusion Criteria Wording:** Lines 30 and 32 state: *"Patients with joint diseases, or other systemic diseases during the perinatal period were excluded"* and *"Individuals with histories of chronic and immune diseases during the perinatal period were excluded"* for an adult cohort aged 17–75 years (mean age 36–38 years), indicating either a mistranslation or unedited boilerplate text.

### 3. Biological / Experimental Grounding & Claim Proportionality
- **Claim 1: *CARD8* `rs2043211` polymorphism contributes to the risk of AS development in the Chinese Han population.** `[Overstated]` — Genotype differences are non-significant ($P > 0.05$), the adjusted allelic 95% CI includes 1.0 ($0.999\text{–}2.072$), and no multiple-testing correction was performed.
- **Claim 2: The interaction of `rs2043211` and `rs7253718` plays an important role in AS development.** `[Methodologically Flawed]` — Inferred solely from a two-SNP Haploview haplotype frequency comparison ($P = 0.008$) where `rs7253718` has no independent effect and no statistical epistasis/interaction term ($\text{SNP}_1 \times \text{SNP}_2$) was tested.

### 4. Reproducibility & Data Completeness
- Tables 1–6 (containing primer sequences, demographic counts, genotype/allele counts, haplotype frequencies, and subgroup counts) and Figure 1 are referenced in the text but are completely missing from the manuscript file.
- No raw genotype data or Sanger validation traces are available.
</Blinded Review: TIME_ANON_0479>
